Neill Moray MacKenzie
Directeur Général chez Trimunocor Ltd.
Profil
Neill Moray MacKenzie is the founder of Trimunocor Ltd.
He is currently a Director at Biotecnol-Serviços e Desenvolvimento SA and a Director & Chief Business Officer at Biotecnol Ltd.
Dr. MacKenzie was formerly the Chief Business Officer & Director at Avidex Ltd.
from 2002 to 2008.
Postes actifs de Neill Moray MacKenzie
| Sociétés | Poste | Début |
|---|---|---|
Biotecnol-Serviços e Desenvolvimento SA
 Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Directeur/Membre du Conseil | - |
Biotecnol Ltd.
 Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Trimunocor Ltd.
 Trimunocor Ltd. Miscellaneous Commercial ServicesCommercial Services Trimunocor Ltd. is a private company based in Harpenden, UK that focuses on developing ground-breaking solutions to protect premature neonates from chronic lung disease. Trimunocor is a spin-out based on IP from the Medical Research Council and University of Southampton. The British company's website provides information about their solution and their focus, as well as news and events. Visitors can also subscribe to stay up to date with the latest developments. The company was founded by Neill Moray MacKenzie and Howard Clark, with Neill Moray MacKenzie serving as CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Neill Moray MacKenzie
| Sociétés | Poste | Fin |
|---|---|---|
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Directeur/Membre du Conseil | 04/12/2008 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Commercial Services |
Biotecnol Ltd.
Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom. | Health Technology |
Trimunocor Ltd.
Trimunocor Ltd. Miscellaneous Commercial ServicesCommercial Services Trimunocor Ltd. is a private company based in Harpenden, UK that focuses on developing ground-breaking solutions to protect premature neonates from chronic lung disease. Trimunocor is a spin-out based on IP from the Medical Research Council and University of Southampton. The British company's website provides information about their solution and their focus, as well as news and events. Visitors can also subscribe to stay up to date with the latest developments. The company was founded by Neill Moray MacKenzie and Howard Clark, with Neill Moray MacKenzie serving as CEO since incorporation. | Commercial Services |